August 6, 2020 and provided by the Russian Direct Investment Fund
shows the vaccine against the coronavirus disease, developed by the
Gamaleya Research Institute of Epidemiology and Microbiology.
Handout / Russian Direct Investment Fund / AFP
Brazilian health regulators said Tuesday they had
approved Johnson & Johnson’s experimental vaccine against the new
coronavirus for the final stage of clinical trials, the fourth
vaccine to receive widespread testing in the hard-hit
country.
The US pharmaceutic al company’s subsidiary Janssen will test
the vaccine on 7,000 volunteers across seven states in Brazil, part
of a group of up to 60,000 worldwide, health regulator Anvisa said
in a statement.
(adsbygoogle = window.adsbygoogle || []).push({});
It said the test would be a randomized, controlled, double-blind
Phase 3 trial, or large-scale testing on humans — the last step
before regulatory approval.
“Another vaccine study has been approved in Brazil, which is a
very important development,” Anvisa official Gustavo Mendes said in
a video on the regulator’s website.
Brazil has become a key testing ground in the search for a
vaccine against COVID-19 since the virus is still spreading fast in
the country.
affected by the COVID-19 coronavirus is treated at a field hospital
set up at a sports gym, in Santo Andre, Sao Paulo state, Brazil, on
May 11, 2020. Miguel SCHINCARIOL / AFP.
The South American nation has the second-highest number of
infections and deaths in the pandemic, after the United States:
nearly 3.5 million and 110,000, respectively.
Brazil has also approved three other Phase 3 trials of vaccine
candidates, developed by Oxford University in partnership with
pharmaceutical firm AstraZeneca, Chinese pharmaceutical firm
Sinovac Biotech, and US firm Pfizer in partnership with Germany’s
BioNTech.
The Brazilian state of Parana also signed a deal last week to
test and produce Russia’s “Sputnik V” vaccine, which
controversially became the first in the world to receive regulatory
approval.
AFP
Read more https://swordpress.com.ng/2020/08/19/brazil-approves-final-tests-for-jj-covid-19-vaccine/